Vaccine
stringclasses 11
values | Dose
stringclasses 9
values | Geography Type
stringclasses 2
values | Geography
stringclasses 79
values | Birth Year/Birth Cohort
stringclasses 21
values | Dimension Type
stringclasses 6
values | Dimension
stringclasses 26
values | Estimate (%)
float64 4.7
100
⌀ | 95% CI (%)
stringlengths 10
13
⌀ | Sample Size
int64 9
63.4k
⌀ |
|---|---|---|---|---|---|---|---|---|---|
PCV
|
≥2 Doses
|
States/Local Areas
|
New Hampshire
|
2019-2020
|
Age
|
5 Months
| 87.4
|
82.7 to 91.0
| 403
|
Hep B
|
≥2 Doses
|
States/Local Areas
|
New Hampshire
|
2019-2020
|
Age
|
5 Months
| 93.6
|
90.3 to 95.8
| 403
|
Hib
|
Primary Series
|
States/Local Areas
|
New Hampshire
|
2019-2020
|
Age
|
13 Months
| 93
|
89.4 to 95.4
| 403
|
Hep B
|
≥2 Doses
|
States/Local Areas
|
New Hampshire
|
2019-2020
|
Age
|
13 Months
| 96
|
93.2 to 97.7
| 403
|
Hib
|
≥2 Doses
|
States/Local Areas
|
New Hampshire
|
2019-2020
|
Age
|
13 Months
| 96.5
|
93.7 to 98.1
| 403
|
Hib
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2019-2020
|
Age
|
13 Months
| 92.7
|
89.1 to 95.2
| 403
|
≥1 Dose MMR
| null |
States/Local Areas
|
New Hampshire
|
2019-2020
|
Age
|
13 Months
| 69.3
|
63.4 to 74.6
| 403
|
DTaP
|
≥4 Doses
|
States/Local Areas
|
New Hampshire
|
2019-2020
|
Age
|
19 Months
| 79.6
|
74.3 to 84.1
| 403
|
Hib
|
≥1 Dose
|
States/Local Areas
|
New Hampshire
|
2019-2020
|
Age
|
3 Months
| 92
|
88.2 to 94.7
| 403
|
DTaP
|
≥1 Dose
|
States/Local Areas
|
New Hampshire
|
2019-2020
|
Age
|
3 Months
| 92.9
|
89.2 to 95.4
| 403
|
Polio
|
≥1 Dose
|
States/Local Areas
|
New Hampshire
|
2019-2020
|
Age
|
3 Months
| 92.2
|
88.3 to 94.8
| 403
|
DTaP
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2019-2020
|
Age
|
13 Months
| 93.5
|
90.2 to 95.8
| 403
|
PCV
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2019-2020
|
Age
|
7 Months
| 76.3
|
70.6 to 81.1
| 403
|
Hib
|
Primary Series
|
States/Local Areas
|
New Hampshire
|
2019-2020
|
Age
|
7 Months
| 78.9
|
73.3 to 83.5
| 403
|
Polio
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2019-2020
|
Age
|
19 Months
| 95.2
|
92.2 to 97.1
| 403
|
PCV
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
35 Months
| 95.8
|
89.4 to 98.9
| 126
|
Hib
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
7 Months
| 73.4
|
62.9 to 81.8
| 126
|
Hib
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2021
|
Age
|
19 Months
| 89.2
|
79.8 to 94.5
| 126
|
Hib
|
Primary Series
|
States/Local Areas
|
New Hampshire
|
2020-2021
|
Age
|
24 Months
| 94.3
|
90.3 to 97.0
| 315
|
Combined 7 Series
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Insurance Coverage
|
Any Medicaid
| 74.9
|
68.7 to 81.1
| 275
|
DTaP
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Insurance Coverage
|
Any Medicaid
| 93.3
|
89.3 to 97.4
| 275
|
Influenza
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
>400% FPL
| 77.7
|
72.2 to 83.2
| 394
|
PCV
|
≥4 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
<133% FPL
| 75.2
|
66.5 to 83.8
| 159
|
Hep A
|
≥1 Dose
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
>400% FPL
| 94.1
|
91.3 to 96.9
| 394
|
Hib
|
Full Series
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
<133% FPL
| 74.9
|
66.3 to 83.6
| 159
|
Hib
|
Full Series
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
133% to <400% FPL
| 88.2
|
83.9 to 92.4
| 335
|
Hib
|
Full Series
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
>400% FPL
| 88.5
|
84.3 to 92.8
| 394
|
Polio
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
<133% FPL
| 86.4
|
79.1 to 93.7
| 159
|
≥1 Dose MMR
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
<133% FPL
| 89.6
|
83.3 to 95.9
| 159
|
DTaP
|
≥4 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
133% to <400% FPL
| 87.5
|
83.2 to 91.8
| 335
|
DTaP
|
≥4 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
>400% FPL
| 90.4
|
86.8 to 94.0
| 394
|
≥1 Dose Varicella
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
<133% FPL
| 90.2
|
84.3 to 96.1
| 159
|
≥1 Dose Varicella
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
133% to <400% FPL
| 89.9
|
85.6 to 94.2
| 335
|
≥1 Dose Varicella
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
>400% FPL
| 95.9
|
93.5 to 98.2
| 394
|
Influenza
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
<133% FPL
| 65.7
|
56.8 to 74.6
| 159
|
Influenza
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
133% to <400% FPL
| 68.6
|
62.5 to 74.7
| 335
|
Hep B
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Overall
|
Overall
| 94.3
|
92.3 to 96.3
| 888
|
DTaP
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Overall
|
Overall
| 95.2
|
93.2 to 97.1
| 888
|
≥1 Dose MMR
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
133% to <400% FPL
| 94.1
|
91.1 to 97.1
| 335
|
DTaP
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
<133% FPL
| 87.3
|
80.1 to 94.4
| 159
|
≥1 Dose MMR
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
>400% FPL
| 96.9
|
95.2 to 98.7
| 394
|
Hep A
|
≥2 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
<133% FPL
| 65.4
|
54.8 to 76.1
| 159
|
Hep B
|
≥1 Dose, 3 Day (Birth Dose)
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
133% to <400% FPL
| 80.6
|
75.5 to 85.6
| 335
|
Hep B
|
≥1 Dose, 3 Day (Birth Dose)
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
>400% FPL
| 78.6
|
73.4 to 83.7
| 394
|
PCV
|
≥4 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
133% to <400% FPL
| 89.9
|
86.2 to 93.6
| 335
|
PCV
|
≥4 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
>400% FPL
| 92.4
|
89.0 to 95.8
| 394
|
≥1 Dose Varicella
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Principal City
| 90.1
|
83.6 to 96.5
| 165
|
Rotavirus
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
<133% FPL
| 73.1
|
64.5 to 81.6
| 159
|
Rotavirus
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
133% to <400% FPL
| 82.9
|
78.0 to 87.9
| 335
|
PCV
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Principal City
| 85.5
|
78.0 to 93.1
| 165
|
PCV
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a Non-MSA
| 94.2
|
90.9 to 97.5
| 339
|
PCV
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Non-Principal City
| 96.8
|
94.7 to 98.8
| 384
|
Hep B
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a Non-MSA
| 95.8
|
93.2 to 98.4
| 339
|
≥1 Dose Varicella
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Non-Principal City
| 94.3
|
91.6 to 97.1
| 384
|
PCV
|
≥4 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a Non-MSA
| 87.9
|
83.3 to 92.4
| 339
|
PCV
|
≥4 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Non-Principal City
| 91.9
|
88.7 to 95.0
| 384
|
Influenza
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Principal City
| 62.8
|
53.7 to 71.9
| 165
|
Combined 7 Series
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a Non-MSA
| 76.2
|
70.3 to 82.1
| 339
|
Combined 7 Series
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Non-Principal City
| 79.1
|
74.2 to 84.1
| 384
|
Influenza
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Non-Principal City
| 76.4
|
71.2 to 81.6
| 384
|
Rotavirus
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Non-Principal City
| 89.6
|
86.0 to 93.1
| 384
|
Rotavirus
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Principal City
| 78.1
|
69.8 to 86.5
| 165
|
Hep A
|
≥1 Dose
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Principal City
| 87
|
80.2 to 93.9
| 165
|
Hep A
|
≥1 Dose
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a Non-MSA
| 88.1
|
84.0 to 92.3
| 339
|
Hep A
|
≥1 Dose
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Non-Principal City
| 92.5
|
89.5 to 95.4
| 384
|
Hep A
|
≥2 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a Non-MSA
| 78.9
|
71.5 to 86.2
| 339
|
Hib
|
Full Series
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Principal City
| 81.9
|
73.9 to 89.9
| 165
|
Hib
|
Full Series
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a Non-MSA
| 87
|
82.3 to 91.7
| 339
|
Hib
|
Full Series
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Non-Principal City
| 86.1
|
81.9 to 90.4
| 384
|
≥1 Dose MMR
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Non-Principal City
| 95.9
|
93.6 to 98.1
| 384
|
Rotavirus
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a Non-MSA
| 82.4
|
77.1 to 87.6
| 339
|
≥1 Dose MMR
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a Non-MSA
| 95.7
|
93.5 to 97.9
| 339
|
Hep A
|
≥2 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Principal City
| 80.9
|
71.9 to 89.9
| 165
|
DTaP
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Principal City
| 87
|
79.6 to 94.4
| 165
|
DTaP
|
≥4 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a Non-MSA
| 85.6
|
80.8 to 90.3
| 339
|
DTaP
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Non-Principal City
| 97.9
|
96.3 to 99.5
| 384
|
DTaP
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a Non-MSA
| 96.2
|
93.5 to 98.9
| 339
|
DTaP
|
≥4 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Principal City
| 79.5
|
71.2 to 87.7
| 165
|
DTaP
|
≥4 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Non-Principal City
| 89.8
|
86.3 to 93.2
| 384
|
Hep B
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Principal City
| 88.9
|
82.2 to 95.6
| 165
|
Influenza
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a Non-MSA
| 71.4
|
65.0 to 77.7
| 339
|
Polio
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Principal City
| 85.5
|
77.9 to 93.1
| 165
|
Polio
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Non-Principal City
| 97.5
|
95.9 to 99.2
| 384
|
Polio
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a Non-MSA
| 96.2
|
93.5 to 98.9
| 339
|
Combined 7 Series
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Principal City
| 72.2
|
63.5 to 81.0
| 165
|
Hep B
|
≥1 Dose, 3 Day (Birth Dose)
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a Non-MSA
| 81.4
|
76.1 to 86.7
| 339
|
Combined 7 Series
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Overall
|
Overall
| 76.7
|
73.2 to 80.3
| 888
|
Polio
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
133% to <400% FPL
| 96
|
93.4 to 98.6
| 335
|
Polio
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
>400% FPL
| 97.5
|
95.6 to 99.4
| 394
|
≥1 Dose Varicella
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a Non-MSA
| 91.4
|
87.5 to 95.3
| 339
|
Hep B
|
≥1 Dose, 3 Day (Birth Dose)
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Non-Principal City
| 79.4
|
74.5 to 84.3
| 384
|
Hep B
|
≥1 Dose, 3 Day (Birth Dose)
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Urbanicity
|
Living In a MSA Principal City
| 78
|
70.0 to 86.0
| 165
|
Hib
|
Full Series
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Overall
|
Overall
| 85.7
|
82.6 to 88.7
| 888
|
Hep B
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
133% to <400% FPL
| 94.8
|
91.9 to 97.7
| 335
|
Hep B
|
≥1 Dose, 3 Day (Birth Dose)
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
<133% FPL
| 81.1
|
73.4 to 88.8
| 159
|
Hep B
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
>400% FPL
| 96.4
|
93.9 to 99.0
| 394
|
Combined 7 Series
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
<133% FPL
| 66.2
|
56.9 to 75.4
| 159
|
Combined 7 Series
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
>400% FPL
| 80.7
|
75.7 to 85.7
| 394
|
DTaP
|
≥3 Doses
|
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
133% to <400% FPL
| 96.5
|
94.1 to 99.0
| 335
|
Combined 7 Series
| null |
States/Local Areas
|
New Hampshire
|
2016-2019
|
Poverty
|
133% to <400% FPL
| 77.9
|
72.5 to 83.4
| 335
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.